{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:33:59Z","timestamp":1793324039123,"version":"4.5.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Soaring Program of Youth Talent Development in Wuhan Children\u2019s Hospital","award":["2023TFJH03"],"award-info":[{"award-number":["2023TFJH03"]}]},{"name":"Children\u2019s Hospital of Fudan University"},{"name":"Excellence Visiting Scholars Program","award":["EKJY2025040104"],"award-info":[{"award-number":["EKJY2025040104"]}]},{"name":"Chen Xiao- ping Foundation for the Development of Science and Technology of Hubei Province","award":["CXPJJH121002-202130"],"award-info":[{"award-number":["CXPJJH121002-202130"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The objective of this study was to validate the achievement of treat-to-target (T2T) in childhood-onset SLE (cSLE) at Wuhan Children\u2019s Hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>This study involved a retrospective application of the childhood-onset lupus low disease activity state (cLLDAS) and remission definitions to prospectively gathered data from a real-world cSLE cohort. Disease activity was evaluated using the SLEDAI 2000 (SLEDAI-2K) and Physician Global Assessment (PGA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>Ninety-seven untreated patients were included in the study, with a median follow-up of 2.6\u2009years. Among them, 75 (77.32%), 70\/97 (72.16%), 64\/90 (65.98%) and 41\/97 (42.27%) patients achieved lupus low disease activity state (LLDAS), childhood-onset lupus disease activity state (cLLDAS), Definitions of Remission in SLE (DORIS) and childhood-onset clinical remission (cCR), respectively. The median times to achieve these targets were 1.22, 1.44, 1.49 and 1.52\u2009years, respectively. The proportions of patients who maintained stability in LLDAS, cLLDAS, DORIS and cCR for over half of the follow-up period (LLDAS\/cLLDAS\/DORIS\/cCR-50) were 40.21%, 30.93%, 23.71% and 19.59%, respectively. Male patients achieved cLLDAS and DORIS earlier. A longer disease duration at initial diagnosis was a positive factor for achieving cLLDAS and cCR. In contrast, glucocorticoid (GC) pulse therapy was a negative predictor for time to cLLDAS and DORIS. Earlier achievement of the first cLLDAS or cCR was associated with a higher probability of reaching cLLDAS-50 and cCR-50.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This single-centre study demonstrates that cLLDAS and cCR are achievable targets in real-life clinical practice. However, maintaining stability in both states remains highly challenging. These findings highlight the need for optimized treatment strategies to improve long-term disease control and outcomes in cSLE, especially for lighter or younger cSLE patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaf620","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T12:57:35Z","timestamp":1764075455000},"source":"Crossref","is-referenced-by-count":5,"title":["Treat-to-target achievement and predictive analysis in childhood-onset systemic lupus erythematosus"],"prefix":"10.1093","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-3879-7411","authenticated-orcid":false,"given":"Wen","family":"Yin","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, Wuhan Children\u2019s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology , Wuhan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Wuhan Children\u2019s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology , Wuhan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Wuhan Children\u2019s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology , Wuhan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Wuhan Children\u2019s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology , Wuhan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Wuhan Children\u2019s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology , Wuhan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Wuhan Children\u2019s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology , Wuhan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3386-1854","authenticated-orcid":false,"given":"Hongxia","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Wuhan Children\u2019s Hospital (Wuhan Maternal and Child Healthcare Hospital), Tongji Medical College, Huazhong University of Science & Technology , Wuhan,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"2026022606030867100_keaf620-B1","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/acr.21757","article-title":"Taxonomy for systemic lupus erythematosus with onset before adulthood","volume":"64","author":"Silva","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026022606030867100_keaf620-B2","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nrrheum.2010.121","article-title":"Prevalence and burden of pediatric-onset systemic lupus erythematosus","volume":"6","author":"Kamphuis","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"2026022606030867100_keaf620-B3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/art.40697","article-title":"Long-term clinical outcomes in a cohort of adults with childhood-onset systemic lupus erythematosus","volume":"71","author":"Groot","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2026022606030867100_keaf620-B4","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/ard-2022-223328","article-title":"Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force","volume":"82","author":"Smith","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2026022606030867100_keaf620-B5","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1136\/annrheumdis-2013-205139","article-title":"Treat-to-target in systemic lupus erythematosus: recommendations from an international task force","volume":"73","author":"van Vollenhoven","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2026022606030867100_keaf620-B6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41584-021-00739-3","article-title":"Treat-to-target in systemic lupus erythematosus: advancing towards its implementation","volume":"18","author":"Parra S\u00e1nchez","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"2026022606030867100_keaf620-B7","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1136\/annrheumdis-2015-207726","article-title":"Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)","volume":"75","author":"Franklyn","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2026022606030867100_keaf620-B8","doi-asserted-by":"crossref","first-page":"109296","DOI":"10.1016\/j.clim.2023.109296","article-title":"PReS-endorsed international childhood lupus T2T task force definition of childhood lupus low disease activity state (cLLDAS)","volume":"250","author":"Smith","year":"2023","journal-title":"Clin Immunol"},{"key":"2026022606030867100_keaf620-B9","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000538","article-title":"2021 DORIS definition of remission in SLE: final recommendations from an international task force","volume":"8","author":"van Vollenhoven","year":"2021","journal-title":"Lupus Sci Med"},{"key":"2026022606030867100_keaf620-B10","doi-asserted-by":"crossref","first-page":"110214","DOI":"10.1016\/j.clim.2024.110214","article-title":"Defining remission in childhood-onset lupus: PReS-endorsed consensus definitions by an international task force","volume":"263","author":"Smith","year":"2024","journal-title":"Clin Immunol"},{"key":"2026022606030867100_keaf620-B11","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/1744666X.2021.1968297","article-title":"Predicting lupus low disease activity state and remission in SLE: novel insights","volume":"17","author":"Gao","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"key":"2026022606030867100_keaf620-B12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/rheumatology\/kew377","article-title":"Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus","volume":"56","author":"Tsang","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2026022606030867100_keaf620-B13","doi-asserted-by":"crossref","first-page":"e000234","DOI":"10.1136\/lupus-2017-000234","article-title":"Remission and low disease activity in systemic lupus erythematosus: an achievable goal even with fewer steroids? Real-life data from a monocentric cohort","volume":"5","author":"Tani","year":"2018","journal-title":"Lupus Sci Med"},{"key":"2026022606030867100_keaf620-B14","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1093\/rheumatology\/keaf057","article-title":"Validation of childhood lupus specific targets: ensuring accurate assessment of disease control in younger, lighter paediatric patients","volume":"64","author":"Sarker","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026022606030867100_keaf620-B15","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026022606030867100_keaf620-B16","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","article-title":"2019 update of the EULAR recommendations for the management of systemic lupus erythematosus","volume":"78","author":"Fanouriakis","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2026022606030867100_keaf620-B17","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1016\/S2665-9913(22)00107-2","article-title":"Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus: the PISCOS study","volume":"4","author":"Piga","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"2026022606030867100_keaf620-B18","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"2026022606030867100_keaf620-B19","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/annrheumdis-2016-209519","article-title":"A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)","volume":"76","author":"van Vollenhoven","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2026022606030867100_keaf620-B20","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13075-017-1256-6","article-title":"Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study","volume":"19","author":"Golder","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"2026022606030867100_keaf620-B21","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1093\/rheumatology\/keab915","article-title":"Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus","volume":"61","author":"Smith","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2026022606030867100_keaf620-B22","doi-asserted-by":"crossref","first-page":"e822","DOI":"10.1016\/S2665-9913(22)00304-6","article-title":"Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study","volume":"4","author":"Kandane-Rathnayake","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"2026022606030867100_keaf620-B23","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1007\/s10067-024-07101-4","article-title":"Active implementation of low disease activity state as a treatment endpoint in childhood-onset systemic lupus erythematosus in routine practice is both feasible and associated with better outcomes","volume":"43","author":"Gotch","year":"2024","journal-title":"Clin Rheumatol"},{"key":"2026022606030867100_keaf620-B24","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1093\/rheumatology\/keaa120","article-title":"Frequencies and predictors of the Lupus Low Disease Activity State and remission in treatment-na\u00efve patients with systemic lupus erythematosus","volume":"59","author":"Gao","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2026022606030867100_keaf620-B25","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000571","article-title":"LLDAS is an attainable treat-to-target goal in childhood-onset SLE","volume":"8","author":"Wahadat","year":"2021","journal-title":"Lupus Sci Med"},{"key":"2026022606030867100_keaf620-B26","doi-asserted-by":"crossref","first-page":"110172","DOI":"10.1016\/j.clim.2024.110172","article-title":"First validation of the childhood lupus low disease activity state (cLLDAS) definition in a real-life longitudinal cSLE cohort","volume":"262","author":"Bergkamp","year":"2024","journal-title":"Clin Immunol"},{"key":"2026022606030867100_keaf620-B27","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000884","article-title":"Usefulness of the lupus low disease activity state as a treatment target in childhood-onset SLE","volume":"10","author":"Cody","year":"2023","journal-title":"Lupus Sci Med"},{"key":"2026022606030867100_keaf620-B28","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1093\/rheumatology\/keae631","article-title":"Association of Lupus Low Disease Activity State And Remission With Reduced Organ Damage And Flare in Systemic lupus erythematosus Patients With High Disease Activity","volume":"64","author":"Kandane-Rathnayake","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026022606030867100_keaf620-B29","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3899\/jrheum.2023-0900","article-title":"Comparison of attainment and protective effects of lupus low disease activity state in patients with newly diagnosed versus established systemic lupus erythematosus","volume":"51","author":"Golder","year":"2024","journal-title":"J Rheumatol"},{"key":"2026022606030867100_keaf620-B30","doi-asserted-by":"crossref","first-page":"e528","DOI":"10.1016\/S2665-9913(24)00121-8","article-title":"Association of sustained lupus low disease activity state with improved outcomes in systemic lupus erythematosus: a multinational prospective cohort study","volume":"6","author":"Golder","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"2026022606030867100_keaf620-B31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s40674-017-0069-8","article-title":"The risk benefit ratio of glucocorticoids in SLE: have things changed over the past 40 years?","volume":"3","author":"Stojan","year":"2017","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"2026022606030867100_keaf620-B32","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1177\/0961203315585813","article-title":"Chinese SLE Treatment and Research group (CSTAR) registry: v. gender impact on Chinese patients with systemic lupus erythematosus","volume":"24","author":"Zhang","year":"2015","journal-title":"Lupus"},{"key":"2026022606030867100_keaf620-B33","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1093\/rheumatology\/kem153","article-title":"Systemic lupus erythematosus in a multiethnic US cohort LUMINA LI: anaemia as a predictor of disease activity and damage accrual","volume":"46","author":"Bertoli","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"2026022606030867100_keaf620-B34","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/S2665-9913(19)30037-2","article-title":"Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study","volume":"1","author":"Golder","year":"2019","journal-title":"Lancet Rheumatol"},{"key":"2026022606030867100_keaf620-B35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/annrheumdis-2011-200106","article-title":"A longitudinal PRINTO study on growth and puberty in juvenile systemic lupus erythematosus","volume":"71","author":"Rygg","year":"2012","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keaf620\/65500882\/keaf620.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/2\/keaf620\/65500882\/keaf620.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/65\/2\/keaf620\/65500882\/keaf620.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T11:03:15Z","timestamp":1772103795000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/doi\/10.1093\/rheumatology\/keaf620\/8342513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,4]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaf620","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,11,25]]},"article-number":"keaf620"}}